181 related articles for article (PubMed ID: 25875801)
1. Metformin suppresses pancreatic tumor growth with inhibition of NFκB/STAT3 inflammatory signaling.
Tan XL; Bhattacharyya KK; Dutta SK; Bamlet WR; Rabe KG; Wang E; Smyrk TC; Oberg AL; Petersen GM; Mukhopadhyay D
Pancreas; 2015 May; 44(4):636-47. PubMed ID: 25875801
[TBL] [Abstract][Full Text] [Related]
2. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.
Lengyel E; Litchfield LM; Mitra AK; Nieman KM; Mukherjee A; Zhang Y; Johnson A; Bradaric M; Lee W; Romero IL
Am J Obstet Gynecol; 2015 Apr; 212(4):479.e1-479.e10. PubMed ID: 25446664
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
5. Recombinant thrombomodulin suppresses tumor growth of pancreatic cancer by blocking thrombin-induced PAR1 and NF-κB activation.
Shirai Y; Uwagawa T; Shiba H; Shimada Y; Horiuchi T; Saito N; Furukawa K; Ohashi T; Yanaga K
Surgery; 2017 Jun; 161(6):1675-1682. PubMed ID: 28094003
[TBL] [Abstract][Full Text] [Related]
6. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
7. Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells.
Chen RY; Xu B; Chen SF; Chen SS; Zhang T; Ren J; Xu J
World J Gastroenterol; 2014 Oct; 20(40):14895-903. PubMed ID: 25356049
[TBL] [Abstract][Full Text] [Related]
8. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway.
Chen H; Zhang J; Luo J; Lai F; Wang Z; Tong H; Lu D; Bu H; Zhang R; Lin S
Oncol Rep; 2013 Aug; 30(2):589-95. PubMed ID: 23754270
[TBL] [Abstract][Full Text] [Related]
10. Methanol extracts of Xanthium sibiricum roots inhibit inflammatory responses via the inhibition of nuclear factor-κB (NF-κB) and signal transducer and activator of transcription 3 (STAT3) in murine macrophages.
Ju A; Cho YC; Cho S
J Ethnopharmacol; 2015 Nov; 174():74-81. PubMed ID: 26232627
[TBL] [Abstract][Full Text] [Related]
11. In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells.
Duan J; Yue W; E J; Malhotra J; Lu SE; Gu J; Xu F; Tan XL
Sci Rep; 2016 Aug; 6():31672. PubMed ID: 27539371
[TBL] [Abstract][Full Text] [Related]
12. Breaking the NF-κB and STAT3 alliance inhibits inflammation and pancreatic tumorigenesis.
Surh YJ; Bode AM; Dong Z
Cancer Prev Res (Phila); 2010 Nov; 3(11):1379-81. PubMed ID: 20978116
[TBL] [Abstract][Full Text] [Related]
13. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
[TBL] [Abstract][Full Text] [Related]
14. Function of nuclear factor kappaB in pancreatic cancer metastasis.
Fujioka S; Sclabas GM; Schmidt C; Frederick WA; Dong QG; Abbruzzese JL; Evans DB; Baker C; Chiao PJ
Clin Cancer Res; 2003 Jan; 9(1):346-54. PubMed ID: 12538487
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
16. Metformin inhibits the growth of human pancreatic cancer xenografts.
Kisfalvi K; Moro A; Sinnett-Smith J; Eibl G; Rozengurt E
Pancreas; 2013 Jul; 42(5):781-5. PubMed ID: 23462329
[TBL] [Abstract][Full Text] [Related]
17. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract][Full Text] [Related]
19. Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways.
Pan Q; Yang GL; Yang JH; Lin SL; Liu N; Liu SS; Liu MY; Zhang LH; Huang YR; Shen RL; Liu Q; Gao JX; Bo JJ
J Exp Clin Cancer Res; 2015 Aug; 34(1):77. PubMed ID: 26245871
[TBL] [Abstract][Full Text] [Related]
20. Metformin suppresses sonic hedgehog expression in pancreatic cancer cells.
Nakamura M; Ogo A; Yamura M; Yamaguchi Y; Nakashima H
Anticancer Res; 2014 Apr; 34(4):1765-9. PubMed ID: 24692708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
